Clinical Trial

The Role of Autoantibodies Against G-protein Coupled Receptors in Obesity

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to explore if GPCR-autoantibodies: 1. are pressent in people living with obesity, and are associated with degree of obesity 2. if it is associated with obesity related diseases
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-04-14.
Trial Details
NCT Number NCT07542327
Lead Sponsor Claus Bogh Juhl
Conditions Obesity, Obesity & Overweight, Obesity Type 2 Diabetes Mellitus, Obesity and Obesity-related Medical Conditions
Enrollment 160 participants
Start Date 2026-09-01
Primary Completion 2027-09-01 (estimated)
Study Completion 2027-09-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-24